Business Card for Nancy Kelly:


Vice President, Digital Marketing
Dallas, TX area
Email Avail: 3 Day Free Trial


108 Wild Basin Rd
Austin, TX 78746

Tel: (214) 479-3773

Last updated on 2018-01-18


About Nancy Kelly:

Nancy Kelly works as an Vice President, Digital Marketing for Texas Instruments at Dallas, TX. The company's webpage is http://www.ti.com. For email, phone number and executive profiles for Vice President, Digital Marketing and other executives of Texas Instruments at Dallas, TX, check Texas Instruments at Joesdata.com. Not the Nancy Kelly you are looking for? Do a quick search in our website and find other people named Nancy Kelly.
Nancy Kelly's Work History:
Internet Marketing Manager
Microcontrollers and Wireless Connectivity at Texas Instruments
Internet Marketing Business Analyst
Microcontrollers at Texas Instruments
Marketing Communications Program Manager
Power Management at Texas Instruments
Online Community Manager
Analog at Texas Instruments
Internet Marketing Associate
Analog at Texas Instruments
Communications Intern at IBM
Marketing Assistant at Wayport
Inc..

Nancy Kelly's Education:
Southern Methodist University - Cox School of Business
The University of Texas at Austin.

Nancy Kelly's Co-workers:
As of September 17, 2021, Nancy Kelly has 1075 co-workers under the company name Texas Instruments at Joesdata.com.

About Texas Instruments:

TranXenoGen, Inc is a biotechnology company focused on developing methods for manufacturing its own therapeutic proteins, as well as generic biologicals. The Company's technology platform has multiple application potentials, including the generation of transgenic chickens for the manufacture of high volume therapeutic proteins, animal models for the study of disease, and high-throughput production of antibodies from genomic-derived targets for product identification. The first of Company's own therapeutic protein products is Anti-Neoplastic Urinary Protein, developed for the treatment of several types of cancer. The Company also intends to utilize its technology for the production of insulin and human serum albumin. The Company is also exploring licensing both its technology and products f...... (Source: SEC reports)


People in the same industry: